These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25158611)

  • 1. Dystrobrevin increases dystrophin's binding to the dystrophin-glycoprotein complex and provides protection during cardiac stress.
    Strakova J; Dean JD; Sharpe KM; Meyers TA; Odom GL; Townsend D
    J Mol Cell Cardiol; 2014 Nov; 76():106-15. PubMed ID: 25158611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Destabilization of the dystrophin-glycoprotein complex without functional deficits in alpha-dystrobrevin null muscle.
    Bunnell TM; Jaeger MA; Fitzsimons DP; Prins KW; Ervasti JM
    PLoS One; 2008 Jul; 3(7):e2604. PubMed ID: 18596960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct pathophysiological mechanisms of cardiomyopathy in hearts lacking dystrophin or the sarcoglycan complex.
    Townsend D; Yasuda S; McNally E; Metzger JM
    FASEB J; 2011 Sep; 25(9):3106-14. PubMed ID: 21665956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent variability of microtubule perturbations associated with dystrophinopathy.
    Belanto JJ; Olthoff JT; Mader TL; Chamberlain CM; Nelson DM; McCourt PM; Talsness DM; Gundersen GG; Lowe DA; Ervasti JM
    Hum Mol Genet; 2016 Nov; 25(22):4951-4961. PubMed ID: 28171583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential distribution of the members of the dystrophin glycoprotein complex in mouse retina: effect of the mdx(3Cv) mutation.
    Dalloz C; Claudepierre T; Rodius F; Mornet D; Sahel J; Rendon A
    Mol Cell Neurosci; 2001 May; 17(5):908-20. PubMed ID: 11358487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential targeting of nNOS and AQP4 to dystrophin-deficient sarcolemma by membrane-directed alpha-dystrobrevin.
    Adams ME; Tesch Y; Percival JM; Albrecht DE; Conhaim JI; Anderson K; Froehner SC
    J Cell Sci; 2008 Jan; 121(Pt 1):48-54. PubMed ID: 18057022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo stretch reveals altered mechanical properties of isolated dystrophin-deficient hearts.
    Barnabei MS; Metzger JM
    PLoS One; 2012; 7(3):e32880. PubMed ID: 22427904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dystrobrevin dynamics in muscle-cell signalling: a possible target for therapeutic intervention in Duchenne muscular dystrophy?
    Blake DJ
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S110-7. PubMed ID: 12206805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dystrophin-glycoprotein complex sequesters Yap to inhibit cardiomyocyte proliferation.
    Morikawa Y; Heallen T; Leach J; Xiao Y; Martin JF
    Nature; 2017 Jul; 547(7662):227-231. PubMed ID: 28581498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dystrobrevin deficiency at the sarcolemma of patients with muscular dystrophy.
    Metzinger L; Blake DJ; Squier MV; Anderson LV; Deconinck AE; Nawrotzki R; Hilton-Jones D; Davies KE
    Hum Mol Genet; 1997 Jul; 6(7):1185-91. PubMed ID: 9215691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.
    Chun JL; O'Brien R; Song MH; Wondrasch BF; Berry SE
    Stem Cells Transl Med; 2013 Jan; 2(1):68-80. PubMed ID: 23283493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological rescue of the dystrophin-glycoprotein complex in Duchenne and Becker skeletal muscle explants by proteasome inhibitor treatment.
    Assereto S; Stringara S; Sotgia F; Bonuccelli G; Broccolini A; Pedemonte M; Traverso M; Biancheri R; Zara F; Bruno C; Lisanti MP; Minetti C
    Am J Physiol Cell Physiol; 2006 Feb; 290(2):C577-82. PubMed ID: 16192300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of dystrophin-associated glycoproteins in the heart lacking dystrophin or dystrophin and utrophin.
    Sharpe KM; Premsukh MD; Townsend D
    J Muscle Res Cell Motil; 2013 Dec; 34(5-6):395-405. PubMed ID: 24096570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of proteasome inhibition in Duchenne and Becker muscular dystrophies.
    Gazzerro E; Assereto S; Bonetto A; Sotgia F; Scarfì S; Pistorio A; Bonuccelli G; Cilli M; Bruno C; Zara F; Lisanti MP; Minetti C
    Am J Pathol; 2010 Apr; 176(4):1863-77. PubMed ID: 20304949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice.
    Williams IA; Allen DG
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1969-77. PubMed ID: 17573457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies.
    Grady RM; Grange RW; Lau KS; Maimone MM; Nichol MC; Stull JT; Sanes JR
    Nat Cell Biol; 1999 Aug; 1(4):215-20. PubMed ID: 10559919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized treatment with a novel FDA-approved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-associated proteins in mdx mice.
    Bonuccelli G; Sotgia F; Capozza F; Gazzerro E; Minetti C; Lisanti MP
    Cell Cycle; 2007 May; 6(10):1242-8. PubMed ID: 17495527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of α1-syntrophin and α-dystrobrevin in skeletal muscles of mdx mice.
    Koo T; Malerba A; Athanasopoulos T; Trollet C; Boldrin L; Ferry A; Popplewell L; Foster H; Foster K; Dickson G
    Hum Gene Ther; 2011 Nov; 22(11):1379-88. PubMed ID: 21453126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profound human/mouse differences in alpha-dystrobrevin isoforms: a novel syntrophin-binding site and promoter missing in mouse and rat.
    Böhm SV; Constantinou P; Tan S; Jin H; Roberts RG
    BMC Biol; 2009 Dec; 7():85. PubMed ID: 19961569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy.
    Siemionow M; Malik M; Langa P; Cwykiel J; Brodowska S; Heydemann A
    Stem Cell Rev Rep; 2019 Dec; 15(6):827-841. PubMed ID: 31612351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.